# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
HC Wainwright & Co. analyst Douglas Tsao downgrades Amryt Pharma (NASDAQ:AMYT) from Buy to Neutral.
Maxim Group analyst Jason McCarthy downgrades Amryt Pharma (NASDAQ:AMYT) from Buy to Hold.
Cantor Fitzgerald analyst Brandon Folkes downgrades Amryt Pharma (NASDAQ:AMYT) from Overweight to Neutral and lowers the pri...
Canaccord Genuity analyst Edward Nash downgrades Amryt Pharma (NASDAQ:AMYT) from Buy to Hold and lowers the price target fro...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 150 points on Monday.